
Chakra Chaulagain MD FACP
351 posts

Chakra Chaulagain MD FACP
@ChaulagainMD
Director of Myeloma and Amyloidosis program at Cleveland Clinic Florida, skilled hematologist with expertise in blood cancers and blood disorders







Breaking News: @ProthenaCorp has announced that the Phase 3 AFFIRM-AL clinical trial evaluating birtamimab in patients with Mayo Stage IV AL #amyloidosis failed to meet its primary endpoint. Learn more: arci.org/negative-affir…











🎉The International Myeloma Society (@Myeloma_Society) has awarded the 2024 Bart Barlogie Clinical Investigator Award to Sagar Lonial, MD, FACP, (@SagarLonialMD) chief medical officer of Winship Cancer Institute of Emory University. ➡️Learn more: brnw.ch/21wNLex

NEW: we may have passed peak obesity 🎉📈📉🙏 In what might be one of the most significant trends I have ever charted, the US obesity rate fell last year.

Newsweek has named @ClevelandClinic the world’s #1 smart hospital, and one of the world’s top hospitals for specialized care, including #1 in urology. Technological advances are key to inventing tomorrow’s care and will help us reach more patients. bit.ly/47rRRMd






FLASCO Clinical Oncology Series: Multiple Myeloma Updates Moderator & Program Chair, @ChaulagainMD, and Sikander Ailawadhi, MD kick off today’s discussion with Diversity, Equity, and Inclusion- Clinical Trial Diversity & Access. #FLASCO #VoiceofOnc #MulipleMyeloma



This past June 8th, the @CleveClinicFL Cancer Centers honored and celebrated past and present cancer patients for their strength & courage, partnering with community cancer organizations & providing resources within the community. Thank you caregivers! @drznahleh @ChaulagainMD




